➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
AstraZeneca
Colorcon
McKesson

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

Gadobenate dimeglumine - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for gadobenate dimeglumine and what is the scope of freedom to operate?

Gadobenate dimeglumine is the generic ingredient in two branded drugs marketed by Bracco and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for gadobenate dimeglumine
Recent Clinical Trials for gadobenate dimeglumine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Early Phase 1
M.D. Anderson Cancer CenterEarly Phase 1
National Cancer Institute (NCI)Phase 2

See all gadobenate dimeglumine clinical trials

Pharmacology for gadobenate dimeglumine
Synonyms for gadobenate dimeglumine
127000-20-8
B 1903617
B-19036/7
B19036/7
D-Glucitol, 1-deoxy-1-(methylamino)-, (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)-N(sup 5),N(sup 8),N(sup 11),O(sup 4),O(sup 5),O(sup 8), O(sup 11),O(sup 13)-gadolinate(2-) (2:1)
Dihydrogen ((+-)-4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-))gadolinate(2-), compound with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
E-7155
Gadobenate Dimeglumine [USAN]
Gadobenate Meglumine
Gadobenic acid
Gadobenic acid dimeglumine salt
Gadolinate(2-), (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)-N(sup 5),N(sup 8),N(sup 11),O(sup 4),O(sup 5),O(sup 8),O(sup 11),O(sup 13))-, dihydrogen, comp. with 1-deoxy-1-(methylami
Gadolinate(2-), (4-carboxy-5,8,11-tris(carboxymethyl)-1-phenyl-2-oxa-5,8,11-triazatridecan-13-oato(5-)-N5,N8,N11,O4,O5,O8,O11,O13)-, dihydrogen, comp. with 1-deoxy-1-(methylamino)-D-glucitol (1:2)
Gd-Bopta/dimeg
HSDB 7546
LS-71353
Multihance
Multihance Multipack
Q21080030

US Patents and Regulatory Information for gadobenate dimeglumine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-001 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-003 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-002 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-001 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-002 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-004 Nov 23, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for gadobenate dimeglumine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-001 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-003 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-002 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE MULTIPACK gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021358-001 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-002 Nov 23, 2004   Start Trial   Start Trial
Bracco MULTIHANCE gadobenate dimeglumine INJECTABLE;INTRAVENOUS 021357-004 Nov 23, 2004   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
AstraZeneca
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.